| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |